Table of Content

1 Nicotinamide Riboside Supplements Market Overview
1.1 Product Overview and Scope of Nicotinamide Riboside Supplements
1.2 Nicotinamide Riboside Supplements Segment by Type
1.2.1 Global Nicotinamide Riboside Supplements Market Value Comparison by Type (2024-2034)
1.2.2 Capsule
1.2.3 Liquid
1.2.4 Softgel
1.3 Nicotinamide Riboside Supplements Segment by Application
1.3.1 Global Nicotinamide Riboside Supplements Market Value by Application: (2024-2034)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Nicotinamide Riboside Supplements Market Size Estimates and Forecasts
1.4.1 Global Nicotinamide Riboside Supplements Revenue 2018-2029
1.4.2 Global Nicotinamide Riboside Supplements Sales 2018-2029
1.4.3 Global Nicotinamide Riboside Supplements Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nicotinamide Riboside Supplements Market Competition by Manufacturers
2.1 Global Nicotinamide Riboside Supplements Sales Market Share by Manufacturers (2018-2024)
2.2 Global Nicotinamide Riboside Supplements Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Nicotinamide Riboside Supplements Average Price by Manufacturers (2018-2024)
2.4 Global Nicotinamide Riboside Supplements Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Nicotinamide Riboside Supplements, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nicotinamide Riboside Supplements, Product Type & Application
2.7 Nicotinamide Riboside Supplements Market Competitive Situation and Trends
2.7.1 Nicotinamide Riboside Supplements Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nicotinamide Riboside Supplements Players Market Share by Revenue
2.7.3 Global Nicotinamide Riboside Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nicotinamide Riboside Supplements Retrospective Market Scenario by Region
3.1 Global Nicotinamide Riboside Supplements Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nicotinamide Riboside Supplements Global Nicotinamide Riboside Supplements Sales by Region: 2018-2029
3.2.1 Global Nicotinamide Riboside Supplements Sales by Region: 2018-2024
3.2.2 Global Nicotinamide Riboside Supplements Sales by Region: 2024-2029
3.3 Global Nicotinamide Riboside Supplements Global Nicotinamide Riboside Supplements Revenue by Region: 2018-2029
3.3.1 Global Nicotinamide Riboside Supplements Revenue by Region: 2018-2024
3.3.2 Global Nicotinamide Riboside Supplements Revenue by Region: 2024-2029
3.4 North America Nicotinamide Riboside Supplements Market Facts & Figures by Country
3.4.1 North America Nicotinamide Riboside Supplements Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nicotinamide Riboside Supplements Sales by Country (2018-2029)
3.4.3 North America Nicotinamide Riboside Supplements Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nicotinamide Riboside Supplements Market Facts & Figures by Country
3.5.1 Europe Nicotinamide Riboside Supplements Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nicotinamide Riboside Supplements Sales by Country (2018-2029)
3.5.3 Europe Nicotinamide Riboside Supplements Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicotinamide Riboside Supplements Market Facts & Figures by Country
3.6.1 Asia Pacific Nicotinamide Riboside Supplements Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nicotinamide Riboside Supplements Sales by Country (2018-2029)
3.6.3 Asia Pacific Nicotinamide Riboside Supplements Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nicotinamide Riboside Supplements Market Facts & Figures by Country
3.7.1 Latin America Nicotinamide Riboside Supplements Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nicotinamide Riboside Supplements Sales by Country (2018-2029)
3.7.3 Latin America Nicotinamide Riboside Supplements Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nicotinamide Riboside Supplements Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicotinamide Riboside Supplements Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nicotinamide Riboside Supplements Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nicotinamide Riboside Supplements Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicotinamide Riboside Supplements Sales by Type (2018-2029)
4.1.1 Global Nicotinamide Riboside Supplements Sales by Type (2018-2024)
4.1.2 Global Nicotinamide Riboside Supplements Sales by Type (2024-2029)
4.1.3 Global Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2029)
4.2 Global Nicotinamide Riboside Supplements Revenue by Type (2018-2029)
4.2.1 Global Nicotinamide Riboside Supplements Revenue by Type (2018-2024)
4.2.2 Global Nicotinamide Riboside Supplements Revenue by Type (2024-2029)
4.2.3 Global Nicotinamide Riboside Supplements Revenue Market Share by Type (2018-2029)
4.3 Global Nicotinamide Riboside Supplements Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nicotinamide Riboside Supplements Sales by Application (2018-2029)
5.1.1 Global Nicotinamide Riboside Supplements Sales by Application (2018-2024)
5.1.2 Global Nicotinamide Riboside Supplements Sales by Application (2024-2029)
5.1.3 Global Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2029)
5.2 Global Nicotinamide Riboside Supplements Revenue by Application (2018-2029)
5.2.1 Global Nicotinamide Riboside Supplements Revenue by Application (2018-2024)
5.2.2 Global Nicotinamide Riboside Supplements Revenue by Application (2024-2029)
5.2.3 Global Nicotinamide Riboside Supplements Revenue Market Share by Application (2018-2029)
5.3 Global Nicotinamide Riboside Supplements Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Thorne
6.1.1 Thorne Corporation Information
6.1.2 Thorne Description and Business Overview
6.1.3 Thorne Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Thorne Nicotinamide Riboside Supplements Product Portfolio
6.1.5 Thorne Recent Developments/Updates
6.2 Codeage
6.2.1 Codeage Corporation Information
6.2.2 Codeage Description and Business Overview
6.2.3 Codeage Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Codeage Nicotinamide Riboside Supplements Product Portfolio
6.2.5 Codeage Recent Developments/Updates
6.3 ProHealth Longevity
6.3.1 ProHealth Longevity Corporation Information
6.3.2 ProHealth Longevity Description and Business Overview
6.3.3 ProHealth Longevity Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.3.4 ProHealth Longevity Nicotinamide Riboside Supplements Product Portfolio
6.3.5 ProHealth Longevity Recent Developments/Updates
6.4 ChromaDex
6.4.1 ChromaDex Corporation Information
6.4.2 ChromaDex Description and Business Overview
6.4.3 ChromaDex Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.4.4 ChromaDex Nicotinamide Riboside Supplements Product Portfolio
6.4.5 ChromaDex Recent Developments/Updates
6.5 HPN Nutraceuticals
6.5.1 HPN Nutraceuticals Corporation Information
6.5.2 HPN Nutraceuticals Description and Business Overview
6.5.3 HPN Nutraceuticals Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.5.4 HPN Nutraceuticals Nicotinamide Riboside Supplements Product Portfolio
6.5.5 HPN Nutraceuticals Recent Developments/Updates
6.6 Cytoplan
6.6.1 Cytoplan Corporation Information
6.6.2 Cytoplan Description and Business Overview
6.6.3 Cytoplan Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Cytoplan Nicotinamide Riboside Supplements Product Portfolio
6.6.5 Cytoplan Recent Developments/Updates
6.7 solodate
6.6.1 solodate Corporation Information
6.6.2 solodate Description and Business Overview
6.6.3 solodate Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.4.4 solodate Nicotinamide Riboside Supplements Product Portfolio
6.7.5 solodate Recent Developments/Updates
6.8 Orgabay
6.8.1 Orgabay Corporation Information
6.8.2 Orgabay Description and Business Overview
6.8.3 Orgabay Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Orgabay Nicotinamide Riboside Supplements Product Portfolio
6.8.5 Orgabay Recent Developments/Updates
6.9 Rossylla
6.9.1 Rossylla Corporation Information
6.9.2 Rossylla Description and Business Overview
6.9.3 Rossylla Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Rossylla Nicotinamide Riboside Supplements Product Portfolio
6.9.5 Rossylla Recent Developments/Updates
6.10 Life Extension
6.10.1 Life Extension Corporation Information
6.10.2 Life Extension Description and Business Overview
6.10.3 Life Extension Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Life Extension Nicotinamide Riboside Supplements Product Portfolio
6.10.5 Life Extension Recent Developments/Updates
6.11 Aesticum
6.11.1 Aesticum Corporation Information
6.11.2 Aesticum Nicotinamide Riboside Supplements Description and Business Overview
6.11.3 Aesticum Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Aesticum Nicotinamide Riboside Supplements Product Portfolio
6.11.5 Aesticum Recent Developments/Updates
6.12 ProHealth
6.12.1 ProHealth Corporation Information
6.12.2 ProHealth Nicotinamide Riboside Supplements Description and Business Overview
6.12.3 ProHealth Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.12.4 ProHealth Nicotinamide Riboside Supplements Product Portfolio
6.12.5 ProHealth Recent Developments/Updates
6.13 NOW
6.13.1 NOW Corporation Information
6.13.2 NOW Nicotinamide Riboside Supplements Description and Business Overview
6.13.3 NOW Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.13.4 NOW Nicotinamide Riboside Supplements Product Portfolio
6.13.5 NOW Recent Developments/Updates
6.14 Double Wood Supplements
6.14.1 Double Wood Supplements Corporation Information
6.14.2 Double Wood Supplements Nicotinamide Riboside Supplements Description and Business Overview
6.14.3 Double Wood Supplements Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Double Wood Supplements Nicotinamide Riboside Supplements Product Portfolio
6.14.5 Double Wood Supplements Recent Developments/Updates
6.15 aSquared Nutrition
6.15.1 aSquared Nutrition Corporation Information
6.15.2 aSquared Nutrition Nicotinamide Riboside Supplements Description and Business Overview
6.15.3 aSquared Nutrition Nicotinamide Riboside Supplements Sales, Revenue and Gross Margin (2018-2024)
6.15.4 aSquared Nutrition Nicotinamide Riboside Supplements Product Portfolio
6.15.5 aSquared Nutrition Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicotinamide Riboside Supplements Industry Chain Analysis
7.2 Nicotinamide Riboside Supplements Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicotinamide Riboside Supplements Production Mode & Process
7.4 Nicotinamide Riboside Supplements Sales and Marketing
7.4.1 Nicotinamide Riboside Supplements Sales Channels
7.4.2 Nicotinamide Riboside Supplements Distributors
7.5 Nicotinamide Riboside Supplements Customers
8 Nicotinamide Riboside Supplements Market Dynamics
8.1 Nicotinamide Riboside Supplements Industry Trends
8.2 Nicotinamide Riboside Supplements Market Drivers
8.3 Nicotinamide Riboside Supplements Market Challenges
8.4 Nicotinamide Riboside Supplements Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Nicotinamide Riboside Supplements Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Nicotinamide Riboside Supplements Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Nicotinamide Riboside Supplements Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nicotinamide Riboside Supplements Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Nicotinamide Riboside Supplements Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Nicotinamide Riboside Supplements Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Nicotinamide Riboside Supplements Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Nicotinamide Riboside Supplements Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Nicotinamide Riboside Supplements, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Nicotinamide Riboside Supplements, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nicotinamide Riboside Supplements, Product Type & Application
Table 12. Global Key Manufacturers of Nicotinamide Riboside Supplements, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nicotinamide Riboside Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Riboside Supplements as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nicotinamide Riboside Supplements Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nicotinamide Riboside Supplements Sales by Region (2018-2024) & (K Units)
Table 18. Global Nicotinamide Riboside Supplements Sales Market Share by Region (2018-2024)
Table 19. Global Nicotinamide Riboside Supplements Sales by Region (2024-2029) & (K Units)
Table 20. Global Nicotinamide Riboside Supplements Sales Market Share by Region (2024-2029)
Table 21. Global Nicotinamide Riboside Supplements Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Nicotinamide Riboside Supplements Revenue Market Share by Region (2018-2024)
Table 23. Global Nicotinamide Riboside Supplements Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nicotinamide Riboside Supplements Revenue Market Share by Region (2024-2029)
Table 25. North America Nicotinamide Riboside Supplements Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nicotinamide Riboside Supplements Sales by Country (2018-2024) & (K Units)
Table 27. North America Nicotinamide Riboside Supplements Sales by Country (2024-2029) & (K Units)
Table 28. North America Nicotinamide Riboside Supplements Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Nicotinamide Riboside Supplements Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nicotinamide Riboside Supplements Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nicotinamide Riboside Supplements Sales by Country (2018-2024) & (K Units)
Table 32. Europe Nicotinamide Riboside Supplements Sales by Country (2024-2029) & (K Units)
Table 33. Europe Nicotinamide Riboside Supplements Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Nicotinamide Riboside Supplements Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nicotinamide Riboside Supplements Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nicotinamide Riboside Supplements Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Nicotinamide Riboside Supplements Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Nicotinamide Riboside Supplements Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Nicotinamide Riboside Supplements Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nicotinamide Riboside Supplements Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nicotinamide Riboside Supplements Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Nicotinamide Riboside Supplements Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Nicotinamide Riboside Supplements Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Nicotinamide Riboside Supplements Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nicotinamide Riboside Supplements Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nicotinamide Riboside Supplements Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Nicotinamide Riboside Supplements Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Nicotinamide Riboside Supplements Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Nicotinamide Riboside Supplements Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nicotinamide Riboside Supplements Sales (K Units) by Type (2018-2024)
Table 51. Global Nicotinamide Riboside Supplements Sales (K Units) by Type (2024-2029)
Table 52. Global Nicotinamide Riboside Supplements Sales Market Share by Type (2018-2024)
Table 53. Global Nicotinamide Riboside Supplements Sales Market Share by Type (2024-2029)
Table 54. Global Nicotinamide Riboside Supplements Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Nicotinamide Riboside Supplements Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nicotinamide Riboside Supplements Revenue Market Share by Type (2018-2024)
Table 57. Global Nicotinamide Riboside Supplements Revenue Market Share by Type (2024-2029)
Table 58. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Type (2018-2024)
Table 59. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Type (2024-2029)
Table 60. Global Nicotinamide Riboside Supplements Sales (K Units) by Application (2018-2024)
Table 61. Global Nicotinamide Riboside Supplements Sales (K Units) by Application (2024-2029)
Table 62. Global Nicotinamide Riboside Supplements Sales Market Share by Application (2018-2024)
Table 63. Global Nicotinamide Riboside Supplements Sales Market Share by Application (2024-2029)
Table 64. Global Nicotinamide Riboside Supplements Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Nicotinamide Riboside Supplements Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nicotinamide Riboside Supplements Revenue Market Share by Application (2018-2024)
Table 67. Global Nicotinamide Riboside Supplements Revenue Market Share by Application (2024-2029)
Table 68. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Application (2018-2024)
Table 69. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Application (2024-2029)
Table 70. Thorne Corporation Information
Table 71. Thorne Description and Business Overview
Table 72. Thorne Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Thorne Nicotinamide Riboside Supplements Product
Table 74. Thorne Recent Developments/Updates
Table 75. Codeage Corporation Information
Table 76. Codeage Description and Business Overview
Table 77. Codeage Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Codeage Nicotinamide Riboside Supplements Product
Table 79. Codeage Recent Developments/Updates
Table 80. ProHealth Longevity Corporation Information
Table 81. ProHealth Longevity Description and Business Overview
Table 82. ProHealth Longevity Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. ProHealth Longevity Nicotinamide Riboside Supplements Product
Table 84. ProHealth Longevity Recent Developments/Updates
Table 85. ChromaDex Corporation Information
Table 86. ChromaDex Description and Business Overview
Table 87. ChromaDex Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. ChromaDex Nicotinamide Riboside Supplements Product
Table 89. ChromaDex Recent Developments/Updates
Table 90. HPN Nutraceuticals Corporation Information
Table 91. HPN Nutraceuticals Description and Business Overview
Table 92. HPN Nutraceuticals Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. HPN Nutraceuticals Nicotinamide Riboside Supplements Product
Table 94. HPN Nutraceuticals Recent Developments/Updates
Table 95. Cytoplan Corporation Information
Table 96. Cytoplan Description and Business Overview
Table 97. Cytoplan Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Cytoplan Nicotinamide Riboside Supplements Product
Table 99. Cytoplan Recent Developments/Updates
Table 100. solodate Corporation Information
Table 101. solodate Description and Business Overview
Table 102. solodate Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. solodate Nicotinamide Riboside Supplements Product
Table 104. solodate Recent Developments/Updates
Table 105. Orgabay Corporation Information
Table 106. Orgabay Description and Business Overview
Table 107. Orgabay Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Orgabay Nicotinamide Riboside Supplements Product
Table 109. Orgabay Recent Developments/Updates
Table 110. Rossylla Corporation Information
Table 111. Rossylla Description and Business Overview
Table 112. Rossylla Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Rossylla Nicotinamide Riboside Supplements Product
Table 114. Rossylla Recent Developments/Updates
Table 115. Life Extension Corporation Information
Table 116. Life Extension Description and Business Overview
Table 117. Life Extension Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Life Extension Nicotinamide Riboside Supplements Product
Table 119. Life Extension Recent Developments/Updates
Table 120. Aesticum Corporation Information
Table 121. Aesticum Description and Business Overview
Table 122. Aesticum Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Aesticum Nicotinamide Riboside Supplements Product
Table 124. Aesticum Recent Developments/Updates
Table 125. ProHealth Corporation Information
Table 126. ProHealth Description and Business Overview
Table 127. ProHealth Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. ProHealth Nicotinamide Riboside Supplements Product
Table 129. ProHealth Recent Developments/Updates
Table 130. NOW Corporation Information
Table 131. NOW Description and Business Overview
Table 132. NOW Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. NOW Nicotinamide Riboside Supplements Product
Table 134. NOW Recent Developments/Updates
Table 135. Double Wood Supplements Corporation Information
Table 136. Double Wood Supplements Description and Business Overview
Table 137. Double Wood Supplements Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Double Wood Supplements Nicotinamide Riboside Supplements Product
Table 139. Double Wood Supplements Recent Developments/Updates
Table 140. aSquared Nutrition Corporation Information
Table 141. aSquared Nutrition Description and Business Overview
Table 142. aSquared Nutrition Nicotinamide Riboside Supplements Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. aSquared Nutrition Nicotinamide Riboside Supplements Product
Table 144. aSquared Nutrition Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Nicotinamide Riboside Supplements Distributors List
Table 148. Nicotinamide Riboside Supplements Customers List
Table 149. Nicotinamide Riboside Supplements Market Trends
Table 150. Nicotinamide Riboside Supplements Market Drivers
Table 151. Nicotinamide Riboside Supplements Market Challenges
Table 152. Nicotinamide Riboside Supplements Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nicotinamide Riboside Supplements
Figure 2. Global Nicotinamide Riboside Supplements Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Nicotinamide Riboside Supplements Market Share by Type in 2022 & 2029
Figure 4. Capsule Product Picture
Figure 5. Liquid Product Picture
Figure 6. Softgel Product Picture
Figure 7. Global Nicotinamide Riboside Supplements Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Nicotinamide Riboside Supplements Market Share by Application in 2022 & 2029
Figure 9. Online Sales
Figure 10. Offline Sales
Figure 11. Global Nicotinamide Riboside Supplements Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Nicotinamide Riboside Supplements Market Size (2018-2029) & (US$ Million)
Figure 13. Global Nicotinamide Riboside Supplements Sales (2018-2029) & (K Units)
Figure 14. Global Nicotinamide Riboside Supplements Average Price (US$/Unit) & (2018-2029)
Figure 15. Nicotinamide Riboside Supplements Report Years Considered
Figure 16. Nicotinamide Riboside Supplements Sales Share by Manufacturers in 2022
Figure 17. Global Nicotinamide Riboside Supplements Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Nicotinamide Riboside Supplements Players: Market Share by Revenue in 2022
Figure 19. Nicotinamide Riboside Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Nicotinamide Riboside Supplements Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Nicotinamide Riboside Supplements Sales Market Share by Country (2018-2029)
Figure 22. North America Nicotinamide Riboside Supplements Revenue Market Share by Country (2018-2029)
Figure 23. United States Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Nicotinamide Riboside Supplements Sales Market Share by Country (2018-2029)
Figure 26. Europe Nicotinamide Riboside Supplements Revenue Market Share by Country (2018-2029)
Figure 27. Germany Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Nicotinamide Riboside Supplements Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Nicotinamide Riboside Supplements Revenue Market Share by Region (2018-2029)
Figure 34. China Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Latin America Nicotinamide Riboside Supplements Sales Market Share by Country (2018-2029)
Figure 42. Latin America Nicotinamide Riboside Supplements Revenue Market Share by Country (2018-2029)
Figure 43. Mexico Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Brazil Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Argentina Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Colombia Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Nicotinamide Riboside Supplements Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Nicotinamide Riboside Supplements Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Nicotinamide Riboside Supplements Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Nicotinamide Riboside Supplements by Type (2018-2029)
Figure 53. Global Revenue Market Share of Nicotinamide Riboside Supplements by Type (2018-2029)
Figure 54. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Nicotinamide Riboside Supplements by Application (2018-2029)
Figure 56. Global Revenue Market Share of Nicotinamide Riboside Supplements by Application (2018-2029)
Figure 57. Global Nicotinamide Riboside Supplements Price (US$/Unit) by Application (2018-2029)
Figure 58. Nicotinamide Riboside Supplements Value Chain
Figure 59. Nicotinamide Riboside Supplements Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed